Taipei, Taiwan, (December 12, 2025) – Bora Pharmaceuticals Co., Ltd.
Partnership creates simplified pathway from early development to commercial launch
Milestone reflects the company’s continued impact in providing global pharmaceutical
Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”) today announced that
Maple Grove, Minnesota, December 1, 2025 – Bora Pharmaceuticals Co.,
MISSISSAUGA (October, 2025) — Bora Pharmaceuticals Co., Ltd. (“Bora” or
Leading CDMO selected amongst hundreds of worldwide nominations by Biotech
Isolator line provides U.S.-based fill/finish capacity for partners in oncology
Contribution Directed to the Ministry of Health and Welfare’s “0923
Taipei, Taiwan, October 13, 2025 – Bora Pharmaceuticals Co., Ltd.
Early 2026 launch of liquid-filled hard capsule capabilities will expand
Buildout includes Gerteis Macro-Pactor® install, with additional investments to follow,
